Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110 USD | +0.66% | +0.50% | -10.56% |
05-03 | UBS Adjusts Price Target on Jazz Pharmaceuticals to $117 From $121, Maintains Neutral Rating | MT |
05-02 | Jazz Pharmaceuticals Q1 Adjusted Earnings Decline, Revenue Rises; Reaffirms 2024 Outlook | MT |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc